Welcome To The BlockRx™ Token Sale

BlockRx

Category: Uncategorized

Hi, Back in August, BlockRx was chosen to be the Solution Showcase at the inaugural Hyperledger Healthcare Working Group’s Virtual Meetup. This presentation gives a brief overview of the project’s history, dives into the technical components of the BlockRx Pharma Ecosystem, describes the current Pharma Supply chain, and explains in some detail how the BlockRx…

Read More

A message from our Director of Pharmaceutical Solutions, Dr. Robert Panetta. The BlockRx Pharma Ecosystem Components: ADLT The BlockRx Pharma Ecosystem is built on three components: the Blockchain, the BlockRx Token, and the Advanced Digital Ledger Technology (ADLT™). The ADLT translates legacy data for the Blockchain, so Pharma can continue using their existing internal systems. It is…

Read More

Gordon Tampol and Carlos Sanchez from BlockRx Meet with Representative of UAE Central Bank at the Dubai ICO Crypto Bazaar Event. On Wednesday, September. 27, we attended the premier InvestBazar & CryptoBazar event at the Rixos Hotel in downtown Dubai. The event was a huge success as we were introduced to a representative of the UAE Central…

Read More

According to a 2014 Whitepaper by The ThomsenGroup, “.. non-adherence with prescription regimens is now a $300 billion problem in the US. The NCBI (National Center for Biotechnology Information )..noted that almost 50% of all prescribed medications are not taken according to directions…and nearly 25% are never initiated.” Non-adherence is problematic both from a National…

Read More

Recently, I spoke to a Pharma Company and asked them how much visibility they had into the manufacturing of APIs and other raw ingredients. The representative responded: “We don’t have any visibility into the API’s”. As with the rest of the supply chain, this lack of visibility has a significant impact on inventory levels and…

Read More

The use of Advanced Digital Ledger Technology™ (ADLT™), of which the Blockchain is an example, can have a tremendous impact on improving the flow of information across the entire supply chain. It empowers biopharmaceutical manufacturers as they now have direct access to supply chain and patient level data without using third party vendors.   But…

Read More